Director/PDMR Shareholding | 15-May-2024 | 14:00 | RNS |
Form 8.3 - Renalytix plc | 15-May-2024 | 08:14 | RNS |
Renalytix Reports Financial Results for Q3 FY2024 | 15-May-2024 | 07:00 | RNS |
Final Results | 15-May-2024 | 07:00 | RNS |
Launch of the Saliva Pregnancy self-test in Boots | 15-May-2024 | 07:00 | RNS |
Amendment to Open Offer timetable | 15-May-2024 | 07:00 | RNS |
Holding(s) in Company | 14-May-2024 | 13:23 | RNS |
Holding(s) in Company | 14-May-2024 | 13:21 | RNS |
Form 8.5 (EPT/RI) - Renalytix plc | 14-May-2024 | 12:00 | RNS |
Publication of Circular and Notice of GM | 14-May-2024 | 07:00 | RNS |
Diaceutics - Capital Markets Event | 14-May-2024 | 07:00 | RNS |
Form 8.3 - Renalytix plc | 14-May-2024 | 07:00 | RNS |
Annual Report and Notice of Annual General Meeting | 13-May-2024 | 17:53 | RNS |
Holding(s) in Company | 13-May-2024 | 14:15 | RNS |
Result of AGM | 13-May-2024 | 13:02 | RNS |
Price | 12,284.05 |
Closing Price Change | -95.05 |
% Change | -0.77 % |
17-May-24 Close | 12,284.05 |
You are here: research